These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 15032318)

  • 1. Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation.
    Huang M; Khor E; Lim LY
    Pharm Res; 2004 Feb; 21(2):344-53. PubMed ID: 15032318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of FITC-chitosan nanoparticles by A549 cells.
    Huang M; Ma Z; Khor E; Lim LY
    Pharm Res; 2002 Oct; 19(10):1488-94. PubMed ID: 12425466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasonication of chitosan and chitosan nanoparticles.
    Tang ES; Huang M; Lim LY
    Int J Pharm; 2003 Oct; 265(1-2):103-14. PubMed ID: 14522123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of the uptake of chitosan oligosaccharide nanoparticles by A549 cells].
    Wan LQ; Hu FQ; Yuan H
    Yao Xue Xue Bao; 2004 Mar; 39(3):227-31. PubMed ID: 15171662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfection efficiency of chitosan vectors: effect of polymer molecular weight and degree of deacetylation.
    Huang M; Fong CW; Khor E; Lim LY
    J Control Release; 2005 Sep; 106(3):391-406. PubMed ID: 15967533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of chitosan and associated insulin in Caco-2 cell monolayers: a comparison between chitosan molecules and chitosan nanoparticles.
    Ma Z; Lim LY
    Pharm Res; 2003 Nov; 20(11):1812-9. PubMed ID: 14661926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake of oleoyl-chitosan nanoparticles by A549 cells.
    Zhang J; Chen XG; Peng WB; Liu CS
    Nanomedicine; 2008 Sep; 4(3):208-14. PubMed ID: 18508414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescent chitosan functionalized magnetic polymeric nanoparticles: Cytotoxicity and in vitro evaluation of cellular uptake.
    Kaewsaneha C; Jangpatarapongsa K; Tangchaikeeree T; Polpanich D; Tangboriboonrat P
    J Biomater Appl; 2014 Nov; 29(5):761-8. PubMed ID: 24951458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.
    Liu X; Howard KA; Dong M; Andersen MØ; Rahbek UL; Johnsen MG; Hansen OC; Besenbacher F; Kjems J
    Biomaterials; 2007 Feb; 28(6):1280-8. PubMed ID: 17126901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of chitosan from mayfly with comparison to commercially available low, medium and high molecular weight chitosans.
    Tan G; Kaya M; Tevlek A; Sargin I; Baran T
    In Vitro Cell Dev Biol Anim; 2018 May; 54(5):366-374. PubMed ID: 29654403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular weight and degree of deacetylation effects on lipase-loaded chitosan bead characteristics.
    Alsarra IA; Betigeri SS; Zhang H; Evans BA; Neau SH
    Biomaterials; 2002 Sep; 23(17):3637-44. PubMed ID: 12109689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between the physical shape and the efficiency of oligomeric chitosan as a gene delivery system in vitro and in vivo.
    Köping-Höggård M; Mel'nikova YS; Vårum KM; Lindman B; Artursson P
    J Gene Med; 2003 Feb; 5(2):130-41. PubMed ID: 12539151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of molecular weight and deacetylation degree of chitosan on the bioaccessibility of quercetin encapsulated in alginate/chitosan-coated zein nanoparticles.
    Carrasco-Sandoval J; Aranda M; Henríquez-Aedo K; Fernández M; López-Rubio A; Fabra MJ
    Int J Biol Macromol; 2023 Jul; 242(Pt 2):124876. PubMed ID: 37182618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles.
    Xu Y; Du Y
    Int J Pharm; 2003 Jan; 250(1):215-26. PubMed ID: 12480287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rational approach towards the design of chitosan-based nanoparticles obtained by ionotropic gelation.
    Kleine-Brueggeney H; Zorzi GK; Fecker T; El Gueddari NE; Moerschbacher BM; Goycoolea FM
    Colloids Surf B Biointerfaces; 2015 Nov; 135():99-108. PubMed ID: 26241921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reporting degree of deacetylation values of chitosan: the influence of analytical methods.
    Khan TA; Peh KK; Ch'ng HS
    J Pharm Pharm Sci; 2002; 5(3):205-12. PubMed ID: 12553887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation.
    Lavertu M; Méthot S; Tran-Khanh N; Buschmann MD
    Biomaterials; 2006 Sep; 27(27):4815-24. PubMed ID: 16725196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphipathic chitosans improve the physicochemical properties of siRNA-chitosan nanoparticles at physiological conditions.
    Martins GO; Segalla Petrônio M; Furuyama Lima AM; Martinez Junior AM; de Oliveira Tiera VA; de Freitas Calmon M; Leite Vilamaior PS; Han SW; Tiera MJ
    Carbohydr Polym; 2019 Jul; 216():332-342. PubMed ID: 31047074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatibility, cellular uptake and biodistribution of the polymeric amphiphilic nanoparticles as oral drug carriers.
    Liu Y; Kong M; Feng C; Yang KK; Li Y; Su J; Cheng XJ; Park HJ; Chen XG
    Colloids Surf B Biointerfaces; 2013 Mar; 103():345-53. PubMed ID: 23247264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel protein-loaded chondroitin sulfate-chitosan nanoparticles: preparation and characterization.
    Yeh MK; Cheng KM; Hu CS; Huang YC; Young JJ
    Acta Biomater; 2011 Oct; 7(10):3804-12. PubMed ID: 21742066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.